Enquire Now
Home
About
Company Overview
Leadership
Sustainability
Overview
Health & Safety
Environment
Responsible Workforce
Ethics
Social Commitment
Responsible Procurement
Compliance
Sustainability Reports
Facilities
Quality
Accreditations
CSR
CDMO Services
Products
Overview
API
Intermediates
Caffeine
Xanthine Derivatives
Acid & Allied
R&D
Investor
Overview
Disclosure
Financial Information
Corporate Governance
Shareholders Information
Code and Policies
Downloads
Annual Reports
Resources
Latest News
Events
Career
Why Aarti Pharmalabs
Job Openings
Contact
Pharma Demerger
Home
Investors
Corporate Governance
Mergers, Demerger and Acquisitions
Pharma Demerger
Investor Menu
Overview
Disclosure
Financial Information
Corporate Governance
Shareholders Information
Code and Policies
Downloads
Annual Reports
Mergers, Demerger and Acquisitions
Regarding Independent Directors
Corporate Governance Report
Pharma Demerger
Sort
Latest
Oldest
Year
2023
2022
2021
Scheme of Arrangement
March 27, 2021
Fair Equity Share Entitlement Ratio
March 27, 2021
Fairness Report
March 27, 2021
Shareholding Pattern
March 27, 2021
Audited Financials
March 27, 2021
Additional Documents
March 27, 2021
Auditors Certificate
March 27, 2021
MOA AOA
March 27, 2021
NCLT Order Sep 21, 2022
March 27, 2022
Newspaper Advertisement - Trading Approval
March 27, 2022
SEBI 19(2)(b) Relaxation Letter
March 27, 2022
BSE Listing In-Principle Approval Letter
March 27, 2022
NSE Listing In-Principle Approval Letter
March 27, 2022
Final Information Memorandum
March 27, 2022
BSE Listing/Trading Approval
March 27, 2023
NSE Listing/Trading Approval
March 27, 2023
Investor Menu
March 27, 2021